Stay updated on Sitagliptin in GVHD Prevention Clinical Trial
Sign up to get notified when there's something new on the Sitagliptin in GVHD Prevention Clinical Trial page.

Latest updates to the Sitagliptin in GVHD Prevention Clinical Trial page
- Check4 days agoChange DetectedA new revision entry labeled v3.5.4 appears in the Record History, replacing the previous v3.5.3. This indicates a minor update to the page’s revision log rather than changes to the study data.SummaryDifference0.1%

- Check11 days agoChange DetectedIndiana University School of Medicine was replaced by Indiana University as the 'Information provided by' affiliation for the study record. This updates the institutional attribution and the responsible party associated with the study's information.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page’s footer/site revision label was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a backend/site software version change rather than a change to the clinical trial record itself.SummaryDifference0.1%

- Check33 days agoChange DetectedRevision v3.5.2 was added; Revision v3.5.0 was removed.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This is a system version update and does not modify study data or page content.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision history updated: added entry v3.4.3 and removed entry v3.4.2 to reflect the latest submission.SummaryDifference0.1%

Stay in the know with updates to Sitagliptin in GVHD Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitagliptin in GVHD Prevention Clinical Trial page.